Patrick C Walsh

Patrick C Walsh

UNVERIFIED PROFILE

Are you Patrick C Walsh?   Register this Author

Register author
Patrick C Walsh

Patrick C Walsh

Publications by authors named "Patrick C Walsh"

Are you Patrick C Walsh?   Register this Author

99Publications

1575Reads

35Profile Views

Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.

Eur Urol Oncol 2020 Jan 13. Epub 2020 Jan 13.

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.12.003DOI Listing
January 2020

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

World J Urol 2019 Dec 6;37(12):2623-2629. Epub 2018 Sep 6.

Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB2 Rm 406, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2477-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401357PMC
December 2019

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.

Int J Radiat Oncol Biol Phys 2019 12 13;105(5):948-956. Epub 2019 Aug 13.

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.08.008DOI Listing
December 2019

Re: Association of Treatment with 5α-Reductase inhibitors with Time to Diagnosis and Mortality in Prostate Cancer.

Authors:
Patrick C Walsh

Eur Urol 2019 Nov 23;76(5):704. Epub 2019 Jul 23.

James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.07.022DOI Listing
November 2019

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Prostate 2018 12 24;78(16):1222-1228. Epub 2018 Jul 24.

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23697DOI Listing
December 2018

Magnetic Resonance Imaging Prior to First Prostate Biopsy-Are we there yet?

Eur Urol 2018 10 14;74(4):409-410. Epub 2018 Jun 14.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183036
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.05.018DOI Listing
October 2018

RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.

Authors:
Patrick C Walsh

J Natl Cancer Inst 2018 Oct 30. Epub 2018 Oct 30.

Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/advance-article/doi/10.1093/jn
Publisher Site
http://dx.doi.org/10.1093/jnci/djy186DOI Listing
October 2018

Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.

Prostate 2018 Jun 19. Epub 2018 Jun 19.

Division of Urology, John and Carol Walter for Urologic Health, NorthShore University HealthSystem, Evanston, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773522PMC
June 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?

J Urol 2018 01 14;199(1):114-119. Epub 2017 Aug 14.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.08.041DOI Listing
January 2018

The Search for the Missing Heritability of Prostate Cancer.

Authors:
Patrick C Walsh

Eur Urol 2017 11 22;72(5):657-659. Epub 2017 Apr 22.

James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.04.003DOI Listing
November 2017

If You Want to Make an Important Discovery, Listen to Your Patients.

Authors:
Patrick C Walsh

Eur Urol 2017 10 22;72(4):482. Epub 2017 Apr 22.

James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.04.001DOI Listing
October 2017

Prostate Cancer Screening.

Authors:
Patrick C Walsh

N Engl J Med 2017 06;376(24):2401-2

Johns Hopkins Hospital, Baltimore, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1705480DOI Listing
June 2017

Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.

BJU Int 2017 03 30;119(3):444-448. Epub 2016 Sep 30.

Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13654DOI Listing
March 2017

Impotence Following Radical Prostatectomy: Insight into Etiology and Prevention.

J Urol 2017 02 21;197(2S):S165-S170. Epub 2016 Dec 21.

James Buchanan Brady Urological Institute, The Johns Hopkins Hospital and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, and Departments of Anatomy and Embryology, and Urology, University of Leiden, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.10.105DOI Listing
February 2017

Technique and outcomes of bladder neck intussusception during robot-assisted laparoscopic prostatectomy: A parallel comparative trial.

Urol Oncol 2016 12 12;34(12):529.e1-529.e7. Epub 2016 Oct 12.

Department of Urology, University of California, Los Angeles, CA; Brady Department of Urology, Weill Cornell Medicine New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.01.012DOI Listing
December 2016

Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?

J Urol 2016 Feb 22;195(2):330-6. Epub 2015 Aug 22.

James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.08.080DOI Listing
February 2016

Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins.

Eur Urol 2016 Feb 23;69(2):191-2. Epub 2015 Oct 23.

University of Melbourne, Department of Surgery and Olivia Newton-John Cancer Research Institute, Austin Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.09.045DOI Listing
February 2016

Joseph J. Kaufman: renaissance man.

Urology 2015 Mar;85(3):487-90

Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.10.039DOI Listing
March 2015

The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.

Eur Urol 2015 Feb 23;67(2):342-6. Epub 2014 Jun 23.

Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.06.015DOI Listing
February 2015

Obesity and long-term survival after radical prostatectomy.

J Urol 2014 Oct 21;192(4):1100-4. Epub 2014 Apr 21.

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Seoul National University Boramae Hospital (SBL), Seoul, South Korea; Sungkyunkwan University Samsung Medical Center (BCJ), Seoul, South Korea; Duke University Medical Center, Durham, North Carolina (SJF). Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.04.086DOI Listing
October 2014

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

BJU Int 2014 May 5;113(5):830-5. Epub 2014 Mar 5.

Department of Oncology, Wayne State University, Detroit, MI, USA; Barbara Ann Karmanos Cancer Institute, Population Studies and Disparities Research Program, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984347PMC
May 2014

The Melbourne Consensus Statement on the early detection of prostate cancer.

BJU Int 2014 Feb;113(2):186-8

Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia; Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic., Australia; Epworth Prostate Centre, Australian Prostate Cancer Research Centre, Epworth Healthcare Richmond, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12556DOI Listing
February 2014

Re: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.

Authors:
Patrick C Walsh

J Natl Cancer Inst 2014 Feb 7;106(2):djt432. Epub 2014 Jan 7.

Affiliation of author: James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt432DOI Listing
February 2014

Prostate cancer, version 1.2014.

J Natl Compr Canc Netw 2013 Dec;11(12):1471-9

From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0174DOI Listing
December 2013

Survival in the prostate cancer prevention trial.

Authors:
Patrick C Walsh

N Engl J Med 2013 11;369(20):1967

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1311498DOI Listing
November 2013

Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance.

J Urol 2013 Oct 30;190(4):1218-22. Epub 2013 Apr 30.

Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.04.071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978170PMC
October 2013

Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy.

BJU Int 2013 Jun 25;111(8):E306-9. Epub 2013 Jan 25.

Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11680.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978182PMC
June 2013

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

BJU Int 2013 May 6;111(5):753-60. Epub 2013 Mar 6.

Department of Urology, The Johns Hopkins Medical Institutions and The James Brady Buchannan Urological Institute, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11611.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978145PMC
May 2013

An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.

BJU Int 2013 Jan 26;111(1):22-9. Epub 2012 Jul 26.

James Buchanan Brady Urological Institute and the Department of Urology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11324.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876476PMC
January 2013

Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

Curr Opin Urol 2013 Jan;23(1):2-4

Department of Urology, New York University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0b013e32835abcf2DOI Listing
January 2013

How surgical innovation reduced death and suffering from prostate cancer.

Authors:
Patrick C Walsh

J Craniofac Surg 2013 Jan;24(1):49-50

From the James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0b013e318270fbe0DOI Listing
January 2013

Prostate-specific antigen concentration in young men: new estimates and review of the literature.

BJU Int 2012 Dec 13;110(11):1627-35. Epub 2012 Apr 13.

Division of Public Health Sciences Alvin J Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11111.xDOI Listing
December 2012

Impact of surgical margin status on prostate-cancer-specific mortality.

BJU Int 2012 Dec 12;110(11):1684-9. Epub 2012 Jul 12.

James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11371.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876479PMC
December 2012

Gleason score 6 adenocarcinoma: should it be labeled as cancer?

J Clin Oncol 2012 Dec 1;30(35):4294-6. Epub 2012 Oct 1.

The Johns Hopkins University and Johns Hopkins Hospital, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.0586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515766PMC
December 2012

The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.

J Urol 2012 Dec 22;188(6):2219-24. Epub 2012 Oct 22.

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.08.028DOI Listing
December 2012

Re: A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

Authors:
Patrick C Walsh

J Urol 2012 Dec 22;188(6):2227-8. Epub 2012 Oct 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.09.069DOI Listing
December 2012

Re: Prostate-specific antigen concentration in young men: new estimates and review of the literature.

Authors:
Patrick C Walsh

J Urol 2012 Nov 19;188(5):1768. Epub 2012 Sep 19.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.07.088DOI Listing
November 2012

Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:
Patrick C Walsh

J Urol 2012 Oct 15;188(4):1181. Epub 2012 Aug 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.06.129DOI Listing
October 2012

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.

BJU Int 2012 Sep 30;110(5):651-7. Epub 2012 Jan 30.

James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicinal Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10875.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489446PMC
September 2012

A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy.

Urology 2012 Aug 5;80(2):247-9. Epub 2012 Jun 5.

Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD 21287-2101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.03.010DOI Listing
August 2012

Re: prediction of erectile function following treatment for prostate cancer.

J Urol 2012 Jun 12;187(6):2094-6. Epub 2012 Apr 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.03.038DOI Listing
June 2012

Re: EPCA-2: a highly specific serum marker for prostate cancer.

Authors:
Patrick C Walsh

J Urol 2012 May 15;187(5):1639. Epub 2012 Mar 15.

View Article

Download full-text PDF

Source
http://www.jurology.com/doi/10.1016/j.juro.2012.01.106
Publisher Site
http://dx.doi.org/10.1016/j.juro.2012.01.106DOI Listing
May 2012

Re: Germline mutations in HOXB13 and prostate cancer risk.

Authors:
Patrick C Walsh

J Urol 2012 Apr 14;187(4):1266-7. Epub 2012 Feb 14.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347120000
Publisher Site
http://dx.doi.org/10.1016/j.juro.2012.01.003DOI Listing
April 2012

Re: Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:
Patrick C Walsh

J Urol 2012 Apr 14;187(4):1267-8. Epub 2012 Feb 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.01.012DOI Listing
April 2012

Re: long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.

Authors:
Patrick C Walsh

J Urol 2012 Mar 20;187(3):909. Epub 2012 Jan 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.11.066DOI Listing
March 2012

Re: radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:
Patrick C Walsh

J Urol 2012 Mar 20;187(3):910. Epub 2012 Jan 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.11.067DOI Listing
March 2012

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.

BJU Int 2012 Sep 30;110(5):651-7. Epub 2012 Jan 30.

James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicinal Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10875.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489446PMC
September 2012